Cases 61 - 70 of 218
Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA Inc.
as 1:2018cv01900
Defendant:
Teva Pharmaceuticals USA Inc.
Plaintiff:
Collegium Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al
as 1:2018cv01895
Defendant:
Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff:
Duchesnay Inc.
Cause Of Action: 35 U.S.C. § 271
Genzyme Corp. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2018cv01796
Defendant:
Teva Pharmaceuticals USA, Inc.
Plaintiff:
The Regents of the University of Michigan and Genzyme Corp.
Cause Of Action: 35 U.S.C. § 271
Insys Therapeutics, Inc. et al v. Teva Pharmaceuticals USA Inc. et al
as 1:2018cv01775
Plaintiff:
Insys Development Company, Inc. and Insys Therapeutics, Inc.
Defendant:
Teva Pharmaceuticals USA Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Teva Pharmaceuticals USA, Inc.
as 1:2018cv01685
Defendant:
Teva Pharmaceuticals USA, Inc. and Catalent Pharma Solutions, LLC
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sun Pharma Global FZE et al v. Teva Pharmaceuticals Industries Limited et al
as 1:2018cv01552
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Industries Limited
Plaintiff:
Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271
Insys Therapeutics, Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2018cv01308
Plaintiff:
Insys Development Company, Inc. and Insys Therapeutics, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals International et al v. Actavis Laboratories FL, Inc. et al
as 1:2018cv01288
Defendant:
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL, Inc. and others
Plaintiff:
Valeant Pharmaceuticals International, Cosmo Technologies Limited and Salix Pharmaceuticals Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc., et al.
as 1:2018cv01039
Defendant:
Teva Pharmaceuticals USA, Inc. and Actavis Elizabeth LLC
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
